One of the most common signs of thalassemia is tiredness. Children may seem more tired than other kids, even after a good ...

Further, Editas Medicine has decreased expenses and costs thanks to discontinuing the development of reni-cel and laying off a sizable portion of its workforce. It expects its cash and equivalents ...

A new study reveals that over one in four Indian children under 12 carry inherited blood disorders. The findings highlight ...

Our Bureau, Bengaluru Wednesday, May 21, 2025, 16:15 Hrs [IST] ...

A three-year study by Metropolis Healthcare reveals that 28.4 per cent of nearly 20,000 children screened for ...

ETHealthworld.com brings latest molecular testing news, views and updates from all top sources for the Indian Health industry.

Mumbai: Nearly 28 out of every 100 children clinically suspected of having inherited blood disorders were found to be ...

Shares of CRISPR Therapeutics have lost momentum in recent years. Despite making significant clinical progress, CRISPR ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

G ene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has been challenging.

Editas Medicine reports successful gene editing levels in stem cells, supporting potential treatment for sickle cell disease and beta thalassemia. Editas Medicine announced promising new data on ...